Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy
- PMID: 35401529
- PMCID: PMC8990319
- DOI: 10.3389/fimmu.2022.859177
Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy
Abstract
Natural killer cells constitute a part of the innate immune system that mediates an effective immune response towards virus-infected and malignant cells. In recent years, research has focused on exploring and advancing NK cells as an active immunotherapy platform. Despite major advances, there are several key challenges that need to be addressed for the effective translation of NK cell research to clinical applications. This review highlights some of these challenges and the innovative strategies being developed to overcome them, including in vitro expansion, in vivo persistence, infiltration to the tumor site, and prevention of exhaustion.
Keywords: NK cell exhaustion; immunotherapy; in vitro expansion; natural Killer (NK) cell; tumor infiltrating cell.
Copyright © 2022 Tarannum, Romee and Shapiro.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
Figures


Similar articles
-
Advancing Natural Killer Cell Therapy: Genetic Engineering Strategies for Enhanced Cancer Immunotherapy.Ann Lab Med. 2025 Mar 1;45(2):146-159. doi: 10.3343/alm.2024.0380. Epub 2025 Jan 8. Ann Lab Med. 2025. PMID: 39774132 Free PMC article. Review.
-
Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review.Arch Pharm Res. 2020 Jan;43(1):32-45. doi: 10.1007/s12272-020-01218-1. Epub 2020 Jan 28. Arch Pharm Res. 2020. PMID: 31993969 Review.
-
Targeting Natural Killer Cells for Tumor Immunotherapy.Front Immunol. 2020 Feb 19;11:60. doi: 10.3389/fimmu.2020.00060. eCollection 2020. Front Immunol. 2020. PMID: 32140153 Free PMC article. Review.
-
Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy.Int J Mol Sci. 2019 Jan 14;20(2):317. doi: 10.3390/ijms20020317. Int J Mol Sci. 2019. PMID: 30646574 Free PMC article. Review.
-
Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment.Front Immunol. 2021 Jun 17;12:683381. doi: 10.3389/fimmu.2021.683381. eCollection 2021. Front Immunol. 2021. PMID: 34220833 Free PMC article. Review.
Cited by
-
iPSC-derived NK cells with site-specific integration of CAR19 and IL24 at the multi-copy rDNA locus enhanced antitumor activity and proliferation.MedComm (2020). 2024 May 9;5(5):e553. doi: 10.1002/mco2.553. eCollection 2024 May. MedComm (2020). 2024. PMID: 38737469 Free PMC article.
-
Three-Dimensional Model Analysis Revealed Differential Cytotoxic Effects of the NK-92 Cell Line and Primary NK Cells on Breast and Ovarian Carcinoma Cell Lines Mediated by Variations in Receptor-Ligand Interactions and Soluble Factor Profiles.Biomedicines. 2024 Oct 20;12(10):2398. doi: 10.3390/biomedicines12102398. Biomedicines. 2024. PMID: 39457710 Free PMC article.
-
Natural Killer Cells Are Key Host Immune Effector Cells Affecting Survival in Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation.Cells. 2022 Nov 2;11(21):3469. doi: 10.3390/cells11213469. Cells. 2022. PMID: 36359863 Free PMC article. Review.
-
Bi- and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives.Blood Cancer J. 2024 Jan 25;14(1):23. doi: 10.1038/s41408-024-00989-w. Blood Cancer J. 2024. PMID: 38272863 Free PMC article. Review.
-
Non-Conventional Allogeneic Anti-BCMA Chimeric Antigen Receptor-Based Immune Cell Therapies for Multiple Myeloma Treatment.Cancers (Basel). 2023 Jan 17;15(3):567. doi: 10.3390/cancers15030567. Cancers (Basel). 2023. PMID: 36765526 Free PMC article. Review.
References
-
- Hu Y, Tian Z, Zhang C. Natural Killer Cell-Based Immunotherapy for Cancer: Advances and Prospects. Engineering (2019) 5:106–14. doi: 10.1016/j.eng.2018.11.015 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical